Ensysce Biosciences, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ENSC | PHRM.CN | 18H0.F | ADXN | SILO | ENVB | |
|---|---|---|---|---|---|---|
| Market cap | 7.19M | 4.55M | 5.11M | 5.33M | 2.93M | 6.53M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -7.4 | -0.5 | — | -60.9 | -1.9 | -1.0 |
| Price/book | -7.7 | 7.1 | -1.1 | 1.4 | 0.3 | 0.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −82.13% | −52.38% | −38.46% | −65.70% | −82.01% | −79.28% |
| Today | −2.12% | −16.67% | −23.81% | +1.27% | +3.91% | −2.67% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ENSC news ›Ensysce Biosciences (NASDAQ:ENSC) & Axsome Therapeutics (NASDAQ:AXSM) Financial Review
Posted by Mitch Edgeman on Oct 31st, 2026 Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) and Ensysce Biosciences (NASDAQ:ENSC – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two…
Ensysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, Dubai
~President James Morrison met Middle East family offices as Ensysce advances CY200 and its severe pain pipeline~ The visit was a central component of Ensysce's expanding global investor and strategic outreach initiative. At the summit, a…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- digitaljournal.com1
- guardonline.com1
- themarketsdaily.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.